Clinical and laboratory aspects of 3,3′,5′-triiodothyronine (reverse T3)
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Reverse T3 (3,3′,5′-triiodothyronine or rT3) is the third most abundant iodothyronine circulating in human blood and is produced by the inner ring deiodination of the pro-hormone thyroxine (T4). Unlike the more abundant and active metabolite T3, the measurement of serum rT3 is yet to find a routine clinical application. As rT3 binds weakly to the T3 thyroid nuclear hormone receptors, it is thought to represent an inactive end-product of thyroid hormone metabolism, diverting T4 away from T3 production. The analysis of serum rT3 has, up until recently, been measured by competitive radioimmunoassay, but these methods have been superseded by mass-spectrometric methods which are less susceptible to interference from other more abundant iodothyronines. Serum rT3 concentration is increased as part of the non-thyroidal illness syndrome, and by administration of common medications such as amiodarone which inhibit the metabolism of rT3. Serum rT3 concentration is also affected by genetic conditions that affect the iodothyronine deiodinases, as well as thyroid transporters and transport proteins. Analysis of rT3 can provide a useful diagnostic fingerprint for these conditions. rT3 has been shown to bind extra-nuclear iodothyronine receptors with a potential role in cell proliferation; however, the clinical relevance of these findings awaits further study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unlike the active T4 metabolite T3, rT3 is an inactive metabolite of T4 as it does not bind or compete with T3 at the T3 receptor.”
In the citing paper
“However, as rT3 assays are not widely available, measurement of T3 is more practical, cheaper, and as effective as measuring rT3 if nonthyroidal illness syndrome is suspected.”
Citations
Cites
The Effects of Amiodarone on the Thyroid*
Martino, E., Bartalena, L., Bogazzi, F., & Braverman, L. E. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0427 · Cited by 551
Deiodinases and their intricate role in thyroid hormone homeostasis
Luongo, C., Dentice, M., & Salvatore, D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0218-2 · Cited by 332
Non-Thyroidal Illness in the ICU: A Syndrome with Different Faces
Van den Berghe, G. (2014) · Thyroid® · doi:10.1089/thy.2014.0201 · Cited by 316
Schoenmakers, E., Agostini, M., Mitchell, C., Schoenmakers, N., Papp, L., Rajanayagam, O., Padidela, R., Ceron-Gutierrez, L., Doffinger, R., Prevosto, C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43653 · Cited by 315 · cited 1×
“The lack of thyroid deiodinase function presents with a characteristic thyroid function test of high serum rT3 and T4, and borderline low T3, which may the first indication that SBP2 action is impaired.(58)”
BackgroundSelf-citationSakurai, A., Takeda, K., Ain, K., Ceccarelli, P., Nakai, A., Seino, S., Bell, G. I., Refetoff, S., & DeGroot, L. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8977 · Cited by 268
A Radioimmunoassay for Measurement of 3,3′, 5′-Triiodothyronine (Reverse T3)
Chopra, I. J. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107795 · Cited by 251
Peeters, R. P., Wouters, P. J., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0535 · Cited by 251
Mentuccia, D., Proietti-Pannunzi, L., Tanner, K., Bacci, V., Pollin, T. I., Poehlman, E. T., Shuldiner, A. R., & Celi, F. S. (2002) · Diabetes · doi:10.2337/diabetes.51.3.880 · Cited by 205
Burch, H. B. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1901214 · Cited by 164
The MCT8 thyroid hormone transporter and Allan–Herndon–Dudley syndrome
Schwartz, C. E., & Stevenson, R. E. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.03.009 · Cited by 162 · cited 1×
“Mutations in the thyroid hormone transporter MCT8 are responsible for the X-linked mental retardation syndrome Allan Herndon Dudley syndrome (AHDS).(59) MCT8 is a specific thyroid hormone transporter that is widely expressed, but notably in the CNS, where it is the major thyroid transmembrane transporter.”
Background
Research works printed but not linked: 5
- The non-thyroidal illness syndrome – PubMed, https://pubmed.ncbi.nlm.nih.gov/25905425/ (accessed 5 July 2020).
- Santini F, 1999, J Clin Endocrinol Metab, 84, 493
- Martino E, 2001, Endocr Rev, 22, 240
- Galland L., 2020, Altern Ther Health Med, 12, 62
- Sarne D., 2016, Thyroid Dis Manager
Cited by
Van Uytfanghe, K., Ehrenkranz, J., Halsall, D., Hoff, K., Loh, T. P., Spencer, C. A., Köhrle, J., & ATA Thyroid Function Tests Writing Group (2023) · Thyroid® · doi:10.1089/thy.2023.0169 · Cited by 100
“88 Measurement of rT3 is widely cited in the lay press as a potential marker to guide T4 or T3 therapy, however, there is currently no evidence to support this application.”
BackgroundSelf-citationSimultaneous Identification of Major Thyroid Hormones by a Nickel Immobilized Biological Nanopore
Wang, K., Yang, X., Xiao, Y., Cao, Z., Zhang, S., Zhang, P., & Huang, S. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c04024 · Cited by 21
Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV
Micali, C., Russotto, Y., Celesia, B. M., Santoro, L., Marıno, A., Pellicanò, G. F., Nunnari, G., & Rullo, E. V. (2022) · Infectious Disease Reports · doi:10.3390/idr14050071 · Cited by 23
“Sick euthyroid syndrome (SES), also known as nonthyroidal illness syndrome (NTIS), is a condition characterized by a consistent decrease in serum fT3 levels with normal fT4 and TSH levels and increased concentration of serum rT3 [45,46].”
BackgroundVanhorebeek, I., Derese, I., Gunst, J., Wouters, P. J., Hermans, G., & den Berghe, G. V. (2021) · Critical Care · doi:10.1186/s13054-021-03858-1 · Cited by 18
“Reverse T3 has long been considered an inactive metabolite of thyroid hormone, considering its weak affinity for nuclear thyroid hormone receptors [36].”
BackgroundXu, C., Gong, M., Wen, S., Zhou, M., Li, Y., & Zhou, L. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s349769 · Cited by 14
Metadata
- Authors
- Halsall, D. J., & Oddy, S.
- Affiliations
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Halsall, David J
- ORCID
- Halsall, David J
- Venue
- Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Publisher
- SAGE Publications
- Published
- 2020-11-04
- Volume
- 58
- Issue
- 1
- Pages
- 29-37
- ISSN
- 0004-5632 (ISSN-L)
- 1758-1001
- OpenAlex
- W3091985994
- Cited by
- 28
- References
- 61
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 5 · 2023: 5 · 2022: 2 · 2021: 1
- FWCI
- 0.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Annals of Clinical Biochemistry International Journal of Laboratory Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- reverse T3, thyroid hormone metabolism, iodothyronine deiodinase, low T3 syndrome, amiodarone, thyroid hormone transporters, thyroid function tests
- MeSH terms
- Amiodarone, Euthyroid Sick Syndromes, Humans, Iodide Peroxidase, Thyroid Gland, Thyroxine, Triiodothyronine, Reverse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical and laboratory aspects of 3,3′,5′-triiodothyronine (reverse T3). https://app.cochat.ai/papers/10.1177/0004563220969150
- The paper
- Halsall, D. J., & Oddy, S. (2021). Clinical and laboratory aspects of 3,3′,5′-triiodothyronine (reverse T3). Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. https://doi.org/10.1177/0004563220969150
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.